STAT+: Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more
STAT
NOVEMBER 19, 2024
patent expires in 2028. Keytruda is a cancer immunotherapy, which stimulates the immune system to attack tumor cells and is the best-selling medicine in the world. The subcutaneous injection could be given in a doctor’s office every six weeks, instead of requiring a 30-minute IV drip at the same interval.
108 
Let's personalize your content